Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
European Journal of Haematology|November 16, 2020
The impact of COVID-19 in the management of AL amyloidosis and Immunoglobulin Deposition Disease: A single-center experienceHolly Lee, Jason Tay, Peter Duggan, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|November 8, 2021
Cyclophosphamide, Bortezomib and Methylprednisolone (CyBorMe) for the Treatment of AL Amyloidosis: Initial Experience From a Single CenterVictor H Jimenez-Zepeda, Holly Lee, Nowell Fine, et al.
Current Oncology (Toronto, Ont.)|September 27, 2024
Doxycycline Plus Bortezomib-Containing Regimens for the Treatment of Light-Chain Amyloidosis in the Frontline Setting: Experience from the Amyloidosis Program of CalgaryEllen Lewis, Nowell Fine, Sylvia McCulloch, et al.
Leukemia & Lymphoma|June 14, 2019
Slow lenalidomide desensitization protocol for patients with multiple myeloma: case series from a single centerPatrick Yau, Victor H Jimenez-Zepeda, Kyla Bailey, et al.
Leukemia & Lymphoma|December 21, 2013
Oligoclonal and monoclonal bands after single autologous stem cell transplant in patients with multiple myeloma: impact on overall survival and progression-free survivalVictor H Jimenez-Zepeda, Donna E Reece, Suzanne Trudel, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 17, 2022
Real-world Outcomes With Cumulative Bortezomib Dose and Efficacy in the Treatment of Transplant-ineligible Multiple Myeloma With Cyclophosphamide, Bortezomib, and DexamethasoneChunpeng Nie, Holly Lee, Jason Tay, et al.
Leukemia & Lymphoma|January 10, 2015
Absolute lymphocyte count as predictor of overall survival for patients with multiple myeloma treated with single autologous stem cell transplantVictor H Jimenez-Zepeda, Donna E Reece, Suzanne Trudel, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 16, 2025
Role of a Multidisciplinary Program (Amyloidosis Program of Calgary) on Recognition and Intervention for AL and ATTR AmyloidosisAksha Burande, Nowell Fine, Robert Jh Miller, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 22, 2017
Early Relapse for Multiple Myeloma Patients Undergoing Single Autologous Stem Cell Therapy: A Single-center ExperienceHolly Lee, Peter Duggan, Ahsan Chaudhry, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 9, 2023
Monoclonal Gammopathy of Undetermined Significance in Patients With Transthyretin Amyloidosis (ATTR): Analysis Using the iStopMM CriteriaEllen Lewis, Holly Lee, Nowell Fine, et al.
Pageof 8